Sanofi's Genzyme Announces European Approval of Framingham Manufacturing Plant
Genzyme, a Sanofi company (NYSE: SNY), announced today that the European Medicines Agency has approved its manufacturing plant in Framingham, Mass., for the production of Fabrazyme® (agalsidase beta).
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.